BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mekky RY, El-Ekiaby N, El Sobky SA, Elemam NM, Youness RA, El-Sayed M, Hamza MT, Esmat G, Abdelaziz AI. Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models. Arch Virol 2019;164:1587-95. [PMID: 30949812 DOI: 10.1007/s00705-019-04232-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang B, Tian L, Xie J, Chen G, Wang F. Targeting miRNAs by natural products: A new way for cancer therapy. Biomed Pharmacother 2020;130:110546. [PMID: 32721631 DOI: 10.1016/j.biopha.2020.110546] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
2 Nafea H, Youness RA, Abou-Aisha K, Gad MZ. LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production. J Cell Physiol 2021;236:5362-72. [PMID: 33368266 DOI: 10.1002/jcp.30234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Abdel-Latif M, Riad A, Soliman RA, Elkhouly AM, Nafae H, Gad MZ, Motaal AA, Youness RA. MALAT-1/p53/miR-155/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer. Mol Cell Biochem 2022. [PMID: 35129780 DOI: 10.1007/s11010-022-04378-4] [Reference Citation Analysis]
4 Mierziak J, Kostyn K, Boba A, Czemplik M, Kulma A, Wojtasik W. Influence of the Bioactive Diet Components on the Gene Expression Regulation. Nutrients 2021;13:3673. [PMID: 34835928 DOI: 10.3390/nu13113673] [Reference Citation Analysis]
5 Yang D, Cao G, Ba X, Jiang H. Epigallocatechin-3-O-gallate promotes extracellular matrix and inhibits inflammation in IL-1β stimulated chondrocytes by the PTEN/miRNA-29b pathway. Pharm Biol 2022;60:589-99. [PMID: 35260041 DOI: 10.1080/13880209.2022.2039722] [Reference Citation Analysis]
6 Sahadevan R, Singh S, Binoy A, Sadhukhan S. Chemico-biological aspects of (-)-epigallocatechin-3-gallate (EGCG) to improve its stability, bioavailability and membrane permeability: Current status and future prospects. Crit Rev Food Sci Nutr 2022;:1-30. [PMID: 35491671 DOI: 10.1080/10408398.2022.2068500] [Reference Citation Analysis]
7 Wu CY, Yu ZY, Chen YC, Hung SL. Effects of epigallocatechin-3-gallate and acyclovir on herpes simplex virus type 1 infection in oral epithelial cells. J Formos Med Assoc 2020:S0929-6646(20)30618-5. [PMID: 33390306 DOI: 10.1016/j.jfma.2020.12.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Wang L, Song J, Liu A, Xiao B, Li S, Wen Z, Lu Y, Du G. Research Progress of the Antiviral Bioactivities of Natural Flavonoids. Nat Prod Bioprospect 2020;10:271-83. [PMID: 32948973 DOI: 10.1007/s13659-020-00257-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
9 Youness RA, Gad AZ, Sanber K, Ahn YJ, Lee GJ, Khallaf E, Hafez HM, Motaal AA, Ahmed N, Gad MZ. Targeting hydrogen sulphide signaling in breast cancer. J Adv Res 2021;27:177-90. [PMID: 33318876 DOI: 10.1016/j.jare.2020.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]